AR042946A1 - Procedimiento para la fabricacion de alcaloides quinazolina - Google Patents

Procedimiento para la fabricacion de alcaloides quinazolina

Info

Publication number
AR042946A1
AR042946A1 ARP040100246A ARP040100246A AR042946A1 AR 042946 A1 AR042946 A1 AR 042946A1 AR P040100246 A ARP040100246 A AR P040100246A AR P040100246 A ARP040100246 A AR P040100246A AR 042946 A1 AR042946 A1 AR 042946A1
Authority
AR
Argentina
Prior art keywords
manufacture
compound
alcaloids
quinazoline
procedure
Prior art date
Application number
ARP040100246A
Other languages
English (en)
Spanish (es)
Inventor
Moormann Joachim Dr
Dr Matusch Rudolf Prof
Hoffmann Hans-Rainer Dr
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32747532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR042946(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of AR042946A1 publication Critical patent/AR042946A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
ARP040100246A 2003-02-03 2004-01-28 Procedimiento para la fabricacion de alcaloides quinazolina AR042946A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10304141A DE10304141B4 (de) 2003-02-03 2003-02-03 Verfahren zur Herstellung von Chinazolin-Alkaloiden

Publications (1)

Publication Number Publication Date
AR042946A1 true AR042946A1 (es) 2005-07-06

Family

ID=32747532

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100246A AR042946A1 (es) 2003-02-03 2004-01-28 Procedimiento para la fabricacion de alcaloides quinazolina

Country Status (25)

Country Link
US (1) US7495096B2 (https=)
EP (1) EP1590351B1 (https=)
JP (1) JP2006516578A (https=)
KR (1) KR20050096165A (https=)
CN (1) CN100558727C (https=)
AR (1) AR042946A1 (https=)
AT (1) ATE407135T1 (https=)
AU (1) AU2004208873B2 (https=)
BR (1) BRPI0407012A (https=)
CA (1) CA2514945A1 (https=)
DE (2) DE10304141B4 (https=)
DK (1) DK1590351T3 (https=)
EA (1) EA009047B1 (https=)
ES (1) ES2314366T3 (https=)
MX (1) MXPA05008179A (https=)
MY (1) MY141734A (https=)
NO (1) NO20053689L (https=)
NZ (1) NZ541101A (https=)
PL (1) PL378406A1 (https=)
PT (1) PT1590351E (https=)
SI (1) SI1590351T1 (https=)
TW (1) TW200418811A (https=)
UA (1) UA81287C2 (https=)
WO (1) WO2004069836A1 (https=)
ZA (1) ZA200505160B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004048927A1 (de) * 2004-10-06 2006-04-20 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren
EP3661502A4 (en) 2017-08-03 2020-12-02 Galectin Sciences, LLC COMPOUNDS FOR THE PREVENTION AND TREATMENT OF MEDICAL CONDITIONS AND THEIR USES
KR102728780B1 (ko) * 2021-11-30 2024-11-08 이화여자대학교 산학협력단 데옥시바시시논을 유효성분으로 포함하는 미백용 조성물 및 상기 데옥시바시시논 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU605614A1 (ru) * 1971-10-20 1978-05-05 Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср Антихолинэстеразное средство
JP3180464B2 (ja) * 1991-08-30 2001-06-25 新日本理化株式会社 ジアセタール化合物の製造方法
DE19530606A1 (de) * 1995-08-21 1997-02-27 Basf Ag 1-(Pyridyl)-pyrazole
JP3958452B2 (ja) * 1997-10-31 2007-08-15 大日精化工業株式会社 新規化学発光試薬及びその製造方法
DE19906975B4 (de) 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906979B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906978B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit

Also Published As

Publication number Publication date
PL378406A1 (pl) 2006-04-03
EA009047B1 (ru) 2007-10-26
MXPA05008179A (es) 2006-02-17
MY141734A (en) 2010-06-15
AU2004208873B2 (en) 2009-12-17
HK1075898A1 (zh) 2005-12-30
DE502004007980D1 (de) 2008-10-16
ZA200505160B (en) 2007-01-31
CA2514945A1 (en) 2004-08-19
US7495096B2 (en) 2009-02-24
KR20050096165A (ko) 2005-10-05
UA81287C2 (en) 2007-12-25
EP1590351B1 (de) 2008-09-03
EA200501135A1 (ru) 2006-02-24
ES2314366T3 (es) 2009-03-16
AU2004208873A1 (en) 2004-08-19
WO2004069836A1 (de) 2004-08-19
US20060084669A1 (en) 2006-04-20
BRPI0407012A (pt) 2006-01-10
DK1590351T3 (da) 2008-12-15
PT1590351E (pt) 2008-11-21
DE10304141B4 (de) 2006-03-09
CN100558727C (zh) 2009-11-11
JP2006516578A (ja) 2006-07-06
TW200418811A (en) 2004-10-01
DE10304141A1 (de) 2004-08-26
EP1590351A1 (de) 2005-11-02
NZ541101A (en) 2009-03-31
SI1590351T1 (sl) 2009-02-28
ATE407135T1 (de) 2008-09-15
NO20053689L (no) 2005-07-29
CN1745084A (zh) 2006-03-08

Similar Documents

Publication Publication Date Title
AR067356A1 (es) Procesos para la preparacion de pirazoles
AR062504A1 (es) Procedimientos para preparar acidos d,l-2hidroxi-4-alquiltiobutiricos
TN2009000199A1 (en) Heteromonocyclic compound and use thereof
UY32142A (es) Preparación de una quinoliniloxidifenilciclopropanodicarboxamida
MA29539B1 (fr) Procedes de production de derives phenoliques 4-biphenylylazetidin -2-one
MX2009003698A (es) Preparacion de azoxistrobina.
ECSP099480A (es) Compuestos químicos 637: piridopirimidindionas como inhibidores de la pde4
DK2190426T3 (da) Griseofulvin-analoger til behandling af cancer ved hæmning af centrosomal clusterdannelse
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
GEP20125512B (en) Process for synthesis of agomelatin
WO2009134531A3 (en) Total synthesis of salinosporamide a and analogs thereof
CU20100099A7 (es) 5-[(3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-onas, un proceso para su producción y su uso como agentes antinflamatorios
AR047739A1 (es) Polimorfos cristalinos de un ligando receptor de cxc-quimiocina
AR074863A1 (es) Proceso y compuestos intermedios para preparar un inhibidor de proteasa macrociclico del vhc
ECSP099070A (es) Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios
UY33325A (es) Purificación mediante adsorción de colorante caramelo
ECSP10010499A (es) Proceso para la preparación de sulfamatos de heteroarilo benzofusionado y la forma cristalina de n-(((2s)-6-cloro-2,3-dihidro-1,4-benzodioxin-2il)metil-sulfamida
ECSP088319A (es) Síntesis de inhibidores de renina que involucra una reacción de cicloadición
AR077332A1 (es) Procesos para la alquilacion de pirazoles
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
AR042946A1 (es) Procedimiento para la fabricacion de alcaloides quinazolina
GT200600207A (es) Proceso para la síntesis de compuestos orgánicos
WO2007083243A3 (en) An improved process for the preparation of risedronate sodium hemi-pentahydrate
AR051936A1 (es) Proceso para la preparacion de pirazoles
AR064215A1 (es) Proceso para obtener el r-enantiomero de salbutamol

Legal Events

Date Code Title Description
FB Suspension of granting procedure